In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 5, 2000, Pages 1309-1315

  Elias, Nizar ^a   Patterson, Bruce W ^a   Schonfeld, Gustav ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein A I; Apolipoprotein B; Familial hypobetalipoproteinemia; Stable isotopes; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; DEUTERIUM; GLYCEROL; LEUCINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC LINKAGE; HUMAN; HYPOBETALIPOPROTEINEMIA; KINETICS; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEIN SECRETION; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034019727     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.5.1309     Document Type: Article

References (40)

1. Kane JP, Havel RJ, Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill Book Co; 1995:1853-1885.
2. Sniderman A, Shapiro S, Marpola D, Skinner B, Tang B, Kwiterovich PO. Association of coronary atherosclerosis with hyperapobetalipoproteinemia. Proc Natl Acad Sci U S A. 1980;77:604-608.
3. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier A, Schmitz M, Gay J, Rader DJ, Gregg RE. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 1992;258:999-1001.
4. Roy CC, Levy E, Green PHR, Sniderman A, Letarte J, Buts JP, Orguin J, Brochu P, Weber AM, Morin CL, Marcel Y, Deckelbaum RJ. Malabsorption, hypocholesterolemia, fat-filled enterocytes with increased intestinal apoprotein B: chylomicron retention disease. Gastroenterology. 1987;92:390-399.
5. Wu J, Kim J, Li Q, Kwok P, Cole T, Cefalu B, Averna M, Schonfeld G. Known mutations of apoB account for only a small minority of hypobetalipoproteinemia. J Lipid Res. 1999;40:955-959.
6. Welty FK, Lahoz C, Tucker KL, Ordovas JM, Wilson PW, Schaefer EJ. Frequency of apoB and apoE gene mutations as causes of hypobetalipoproteinemia in the Framingham offspring population. Arterioscler Thromb Vasc Biol. 1998;18:1745-1751.
7. Schonfeld G. The hypobetalipoproteinemias. Annu Rev Nutr. 1995;15: 23-34.
8. Linton MF, Farese RV, Young SG. Familial hypobetalipoproteinemia. J Lipid Res. 1993;34:521-541.
9. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G. Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate (in vivo studies in apoB-89, apoB-75, apoB-54.8, and apoB 31 heterozygotes). J Lipid Res. 1996;37:844-852.
10. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G. Lipoproteins containing the truncated apolipoprotein, apoB-89, are cleared from human plasma more rapidly than apoB-100 containing lipoproteins in vivo. J Clin Invest. 1992;89:1931-1937.
11. Krul ES, Parhofer KG, Barrett PHR, Wagner RD, Schonfeld G. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. J Lipid Res. 1992;33:1037-1050.
12. Aguilar-Salinas CA, Barrett PHR, Parhofer KG, Young SG, Tessareau D, Bateman J, Quinn C, Schonfeld G. Apolipoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler Thromb. 1995;15:71-80.
13. Fazio S, Sidoli A, Vivenzio A, Maletta A, Giampaoli S, Menotti A, Antonini R, Urbinati G, Baralle FE, Ricci G. A form of familial hypobetalipoproteinemia not due to a mutation in the apolipoprotein-B gene. J Intern Med. 1991;229:41-47.
14. Pulai JI, Neuman RJ, Groenewegen AW, Wu J, Schonfeld G. Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families. Am J Med Genet. 1998;76:79-86.
15. Yuan B, Neuman R, Duan SH, Weber JL, Kwok PY, Saccone NL, WU JS, Liu KY, Schonfeld G. Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22. Am J Hum Genet. In press.
16. Cole TG, Kitchens RT, Daugherty A, Schonfeld G. An improved method of separation of triglyceride-rich lipoproteins by FPLC. Pharm Biocommun. 1988;4:4-6.
17. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1983;128:417-431.
18. Parhofer KG, Barrett PH, Bier DM, Schonfeld G. Determination of kinetic parameters of apolipoprotein-B metabolism using amino-acids labeled with stable isotopes. J Lipid Res. 1991;32:1311-1323.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
20. Adams RF. Determination of amino acid profiles in biological samples by gas chromatography. J Chromatogr. 1974;95:189-212.
21. Klein RL, Zilversmit DB. Direct determination of human and rabbit apolipoprotein B selectively precipitated with butanol-isopropyl ether. J Lipid Res. 1984;25:1380-1386.
22. Patterson BW, Hachey DL, Cook GL, Amann JM, Klein PD. Incorporation of a stable isotopically labeled amino acid into multiple human apolipoproteins. J Lipid Res. 1991;32:1063-1072.
23. Patterson BW, Zhao G, Elias N., Hachey DL, Klein S. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res. 1999;40:2118-2124.
24. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol. 1999;276:E278-E284.
25. Elias N, Patterson BW, Schonfeld G. Decreased production rates of VLDL triglycerides and apolipoprotein B 100 in subjects heterozygotes for familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 1999;19:2714-2721.
26. Zech LA, Grundy SM, Steinberg D, Berman M. Kinetic model for production and metabolism of very low density lipoprotein triglycerides: evidence for a slow production pathway and results for normolipidemic subjects. J Clin Invest. 1979;63:1262-1273.
27. Young SG, Krul ES, McCormick S, Farese RV Jr, Linton MF. Identification and characterization of truncated forms of apolipoprotein B in hypobetalipoproteinemia. Methods Enzymol. 1996;263:120-145.
28. Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B. Kinetic basis of the primary hyperlipidemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest. 1980;10:161-172.
29. Welty FK, Lichtenstein AH, Barrett PHR, Dolnikowski GG, Ordovas JM, Schaefer EJ. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Arterioscler Thromb Vasc Biol. 1997;17:881-888.
30. Ginsberg HN. Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr Opin Lipidol. 1995;6:275-280.
31. Benoist F, Grand-Perret T. ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools. Arterioscler Thromb Vasc Biol. 1996;16:1229-1235.
32. Cianflone KM, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1990;31:2045-2055.
33. Jamil H, Gordon DA, Eustice DC, Brooks CM, Dickson JK Jr, Chen Y, Ricci B, Chu CH, Harrity TW, Closek CP Jr, Biller SA, Gregg RE, Wetterau JR. An inhibitor of microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc Natl Acad Sci U S A. 1996;93:11991-11995.
34. Sakata N, Wu X, Dixon JL, Ginsberg HN. Proteolysis and lipid facilitated translocation are distinct but competitive processes which regulate secretion of apolipoprotein B in HepG2 cells. J Biol Chem. 1993;268: 22967-22970.
35. Brown MS, Goldstein JL. Receptor-mediated control of cholesterol metabolism. Science. 1976;191:151-1554.
36. Parhofer KG, Barrett PHR, Demant T, Richter WO, Schwandt P. Effect of apheresis on kinetic parameters of apoprotein B metabolism in familial hypercholesterolemia. Circulation. 1996;94:1-583.
37. Brinton EA, Eisenberg S, Breslow JL. Increased apoA-I and apoA-II fractional catabolic rates in patients with low high density lipoproteincholesterol levels with or without hypertriglyceridemia. J Clin Invest. 1991;87:536-544.
38. Emmerich J, Verges B, Tauveron I, Rader D, Santamarina-Fojo S, Schaefer J, Ayraultl-Jarrier M, Thieblot P, Brewer HB Jr. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I. Arterioscler Thromb. 1993;13:1299-1306.
39. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size: effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb Vasc Biol. 1994;14:707-720.
40. Lamarche B, Uffelman KD, Carpentier A, Conn JS, Steiner G, Barrett PH, Lewis GF. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apoA-I in healthy men. J Clin Invest. 1999;103: 1191-1199.